| Financial Year |
March 31 2021 |
| Monetary Funds |
16,307,140.33 |
| Held-for-trading Financial Assets |
195,954,206.53 |
| Notes Receivable |
-- |
| Accounts Receivable |
5,717,389.97 |
| Advances to Suppliers |
7,610,129.97 |
| Other Receivables |
1,368,782.29 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
19,711,833.36 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
1,313,086.50 |
| Total Current Assets |
247,982,568.95 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
20,197,347.31 |
| Under-construction Projects |
112,707,961.38 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
31,193,745.21 |
| R&D expenses |
33,914,360.77 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
6,723,814.85 |
| Deferred Income Tax Assets |
5,697,621.28 |
| Other Non-Current Assets |
2,559,391.33 |
| Sub-Total of Non-Current Assets |
222,344,266.29 |
| Total Assets |
470,326,835.24 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
29,924,058.29 |
| Accounts Received In Advance |
644,879.51 |
| Employee Compensation Payable |
4,102,493.98 |
| Taxes Payable |
451,646.37 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
1,713,825.02 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
110,245.08 |
| Sub-Total of Current Liabilities |
38,106,514.60 |
| Long-term Loans |
68,787,699.78 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
83,757,036.84 |
| Total Liabilities |
121,863,551.44 |
| Paid-In Capital(Or Share Stock) |
49,547,185.00 |
| Capital Surplus |
259,827,532.75 |
| Surplus Reserve |
3,370,843.71 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
32,081,321.27 |
| Minority Stockholder's Interest |
3,636,401.07 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
344,826,882.73 |
| Owner's Equity（Stockholder's Equity） |
348,463,283.80 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
470,326,835.24 |
